Stroke Revisited: Dyslipidemia in Stroke, 1st ed. 2021 Stroke Revisited Series
Coordonnateurs : Lee Seung-Hoon, Kang Min Kyoung
1. Role of Dyslipidemia in Atherosclerosis
2. Effects of Dyslipidemia on the Cerebral vessels
Part II. Clinical Significance of Dyslipidemia in Stroke
3. Impact of Dyslipidemia on Ischemic Stroke
4. Dyslipidemia and Hemorrhagic Stroke5. Clinical biomarkers of Dyslipidemia
Part III. Treatment of Dyslipidemia in Stroke Patients
6. Therapeutic Lifestyle Modification
7. Statins8. Ezetimibe
9. Fibrate and Niacin
10. Fish Oils
11. PCSK9 inhibiting monoclonal antibodies12. PCSK9 inhibiting siRNA
13. Understanding of Clinical Practice Guidelines for Dyslipidemia
Part Ⅳ. Management of Dyslipidemia in Clinical Practice of Stroke
14. Practical Management of Dyslipidemia in Stroke Patients15. Practical Dyslipidemia Management in Stroke-specific Situations
16. Dyslipidemia in Women: Etiology and Management
17. Safety Considerations of Pharmacological Treatment
Min Kyoung Kang, MD
Department of Neurology, Uijeongbu Eulji Medical CenterGyeonggi, Republic of Korea
Presents state of the art knowledge
Covers both basic and clinical aspects in detail
Evaluates currently available treatment modalities
Discusses a range of specific considerations
Provides clear management guidance
Date de parution : 08-2022
Ouvrage de 219 p.
17.8x25.4 cm
Date de parution : 08-2021
Ouvrage de 219 p.
17.8x25.4 cm
Thème de Stroke Revisited: Dyslipidemia in Stroke :
Mots-clés :
dyslipidemia; stroke; atherosclerosis; cardiovascular disease; biomarker